In a research about pancreatic cancer, the expression of ALKBH5 was found downregulated in tumor cells and could inhibit cells by demethylating the lncRNA KCNK15-AS1, which can be used in prognostics and therapy strategies (He et al., 2018). This evidence concerns the gene ALKBH5 and pancreatic neoplasm.